Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies
Zhaoyang Li(National Institute of Allergy and Infectious Diseases), Eduardo Dávila(University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center)
Cited by 69